Ketofelt Eye Drops contain Ketotifen 0.25 mg, a dual-acting antihistamine and mast cell stabilizer formulated for the management of allergic conjunctivitis and other ocular allergy conditions.
Ketotifen works by blocking histamine release and preventing mast cell degranulation, thereby reducing itching, redness, watering, and ocular irritation associated with eye allergies.
From a commercial perspective, Ketofelt Eye Drops are a high-demand anti-allergic ophthalmic product, frequently prescribed in eye clinics, general practice settings, and allergy care centers, ensuring consistent sales and repeat prescriptions.
Adding Ketofelt Eye Drops to your portfolio strengthens the ophthalmic anti-allergic segment, offering seasonal demand stability, strong prescriber preference, and reliable growth opportunities for PCD pharma franchise partners.